KSR2 Genotype

If you have struggled with weight since childhood, or if severe obesity runs in your family without an obvious explanation, the answer may not be in your behavior. A small number of people carry rare inherited changes in a gene called KSR2 (kinase suppressor of Ras 2) that quietly shift how their body handles fuel. This test reads those changes.

KSR2 is one of the rare obesity genes where the science has moved beyond association into proven biology. Carriers of certain variants have been shown in lab studies to have reduced KSR2 protein function, and in a meta-analysis of about 719,000 people, one specific change was linked to higher body mass index per copy carried. Knowing whether you carry one of these variants reframes the conversation about your weight from willpower to wiring.

What KSR2 Actually Does

KSR2 is what biologists call a scaffold protein, meaning it acts like a workbench inside your cells that holds other signaling molecules in place so they can talk to each other. It organizes a chain of messengers known as the Ras/Raf/MEK/ERK pathway, which helps cells decide whether to grow, divide, or change function. It also helps regulate AMPK, a master energy sensor that controls how your body produces heat, burns fat, and processes glucose.

KSR2 is highly expressed in the brain, and brain-specific animal studies show that central KSR2 plays a major role in body weight regulation. That said, peripheral tissues also contribute, with KSR2 influencing leptin sensitivity and AMPK signaling outside the brain as well. The gene appears to shape body weight primarily through how the brain regulates appetite and energy use, with supporting effects in other tissues that handle fuel.

Severe and Early-Onset Obesity

The strongest human evidence for KSR2 sits in the obesity space. Researchers analyzing genetic data from roughly 719,000 people identified a rare variant called p.Arg525Gln associated with higher body mass index per copy carried, with rare-variant effect sizes about 10 times larger than typical common variants. That is a per-allele effect, meaning each inherited copy adds independently. The gene itself is highly intolerant to loss-of-function mutations, a sign that the body works hard to keep KSR2 working normally.

Two other rare variants, T193I and I402F, have been found in people with severe obesity in a community study of 6,803 adults. Lab experiments showed that both variants produce a protein that does not function properly. In a UK Biobank analysis of about 419,581 people, predicted protein-truncating variants in KSR2 (changes that essentially shorten or break the protein) were associated with a larger recalled childhood body size, pointing to an effect that begins early in life.

Why Variable Risk Matters Here

Carrying a KSR2 variant does not guarantee you will develop obesity. In the UK Biobank, among carriers of variants in autosomal-dominant obesity genes including KSR2, the share who actually became obese ranged from 8% to 29%, with a median of 23%. The general UK Biobank obesity rate was about 24%. In plain terms: the variant raises risk in carriers as a group, but many carriers fall into a normal weight range, especially in adulthood. Childhood appears to be when the effect is most visible.

This is the practical meaning of penetrance: a risk variant changes your odds, not your destiny. The same KSR2 finding in two people can play out differently depending on the rest of their genetic background, environment, and lifestyle. That is why the test result is most useful when combined with your weight history, family history, and other risk markers, rather than read in isolation.

KSR2 and Tumor Biology

KSR2 also appears in research on a rare cancer context. In thymic neuroendocrine tumors associated with the MEN1 syndrome, KSR2 was the single most strongly upregulated gene, described as abundantly expressed compared with normal thymus tissue. This is a change in how much KSR2 protein the tumor cells produce, not a change in the inherited KSR2 sequence the test reports. The finding raises KSR2 as a potential drug target in that specific tumor type, but it does not change how you should interpret your inherited genotype.

A Related Gene Worth Naming

There is a separate gene called CNKSR2, short for connector enhancer of KSR2. Mutations in CNKSR2 have been described in families with a rare seizure and language-loss condition called the epilepsy-aphasia spectrum, inherited on the X chromosome. CNKSR2 is a different gene from KSR2 despite the similar name. This test reads KSR2, not CNKSR2, and findings about one do not transfer to the other.

Why One Test Is Enough

The KSR2 genotype is part of your inherited DNA. It does not change over your lifetime, so this is a one-time test. What does need ongoing tracking is the downstream picture of how your body is responding: body weight, body composition, fasting insulin and glucose, HbA1c, and lipids. If you carry a variant associated with reduced KSR2 function, those phenotype markers become more useful to monitor, ideally at baseline, again at 3 to 6 months if you make changes, and at least annually thereafter.

What to Do With an Out-of-Pattern Result

If your result identifies a rare KSR2 variant associated with reduced function or higher body weight, the next steps are about widening the workup, not retesting the gene. Useful companions include a fasting insulin and glucose panel, HbA1c, lipids, and liver enzymes to gauge how the variant may be expressing itself in your metabolism right now. Body composition testing gives a sharper picture than scale weight alone.

A conversation with a genetic counselor or an obesity medicine specialist is reasonable, particularly if you have severe early-onset obesity, insulin resistance, or a strong family history. Biological family members, especially children and siblings, may benefit from knowing the result, because the variants follow inheritance patterns that can be traced. None of this requires waiting for a diagnosis. The result is information you can act on now.

How to Read This Result Honestly

KSR2 testing sits in the research-leaning end of the clinical genetics spectrum. The variants linked to obesity are rare, the effect of any single variant is modest on average, and the share of carriers who actually develop obesity varies widely. A negative result on this test does not rule out a genetic contribution to weight, since many other genes can be involved, and a negative result only rules out the specific variants the assay tests for. A positive result is meaningful context, not a verdict. Use it as one input into a broader picture that includes your metabolic numbers and your family history.